|
|
||||||||
The Journal of Immunology, Vol 132, Issue 6 2736-2741, Copyright © 1984 by American Association of Immunologists
ARTICLES |
CO Elson and W Ealding
Cholera toxin (CT) has been found to be an extremely potent immunogen for mucosal IgA responses when administered via the intestine. This study has examined both mucosal and systemic immune responses after feeding CT and compared these responses with those obtained after feeding keyhole limpet hemocyanin (KLH), another protein that is strongly immunogenic in mice. Feeding CT to mice resulted not only in IgA antibody in intestinal secretions but also resulted in substantial plasma IgG and IgA antibody levels. Feeding KLH in much larger quantity resulted in little or no antibody response in intestinal secretions or plasma. Lymphoid cells from various tissues of mice fed CT were cultured in vitro for 10 days and the supernatant was tested for antibody to CT. Spontaneous antibody synthesis (no antigen added to cultures) was present in cultures of each cell type, but IgG anti-CT was found mainly in cultures of spleen and mesenteric lymph node cells and IgA anti-CT mainly in cultures of Peyer's patch and lamina propria cells. Peyer's patch cells cultured with CT as antigen synthesized both IgG and IgA anti-CT, suggesting that the antibody response to both isotypes originated in this site. Helper T cell activity for both IgA and IgG anti-CT was detected in spleens, mesenteric lymph nodes, and Peyer's patches. Lastly, when KLH and CT were fed to mice at the same time, an intestinal IgA anti-KLH and plasma IgG anti-KLH response was stimulated, a response pattern similar to that occurring to CT after CT was fed alone. We conclude that mucosal stimulation by CT generates both a systemic IgG and mucosal IgA response to this antigen, and that CT can cause a similar pattern of response to an unrelated protein antigen when both are administered into the intestine at the same time. The data favor the idea that both the IgG and IgA responses originate in GALT and then disseminate to other tissues. We propose that CT accomplishes these effects by altering the regulatory environment within GALT.
This article has been cited by other articles:
![]() |
J. Flores, H. L. DuPont, S. A. Lee, J. Belkind-Gerson, M. Paredes, J. A. Mohamed, L. Y. Armitige, D.-C. Guo, and P. C. Okhuysen Influence of Host Interleukin-10 Polymorphisms on Development of Traveler's Diarrhea Due to Heat-Labile Enterotoxin-Producing Escherichia coli in Travelers from the United States Who Are Visiting Mexico Clin. Vaccine Immunol., August 1, 2008; 15(8): 1194 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ahrendt, S. I. Hammerschmidt, O. Pabst, R. Pabst, and U. Bode Stromal Cells Confer Lymph Node-Specific Properties by Shaping a Unique Microenvironment Influencing Local Immune Responses J. Immunol., August 1, 2008; 181(3): 1898 - 1907. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wakabayashi, Y. Nakagawa, M. Shimizu, K. Moriya, Y. Nishiyama, and H. Takahashi Suppression of an Already Established Tumor Growing through Activated Mucosal CTLs Induced by Oral Administration of Tumor Antigen with Cholera Toxin J. Immunol., March 15, 2008; 180(6): 4000 - 4010. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Duverger, R. J. Jackson, F. W. van Ginkel, R. Fischer, A. Tafaro, S. H. Leppla, K. Fujihashi, H. Kiyono, J. R. McGhee, and P. N. Boyaka Bacillus anthracis Edema Toxin Acts as an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine Antigens J. Immunol., February 1, 2006; 176(3): 1776 - 1783. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. van Ginkel, R. J. Jackson, N. Yoshino, Y. Hagiwara, D. J. Metzger, T. D. Connell, H. L. Vu, M. Martin, K. Fujihashi, and J. R. McGhee Enterotoxin-Based Mucosal Adjuvants Alter Antigen Trafficking and Induce Inflammatory Responses in the Nasal Tract Infect. Immun., October 1, 2005; 73(10): 6892 - 6902. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ohmura, M. Yamamoto, C. Tomiyama-Miyaji, Y. Yuki, Y. Takeda, and H. Kiyono Nontoxic Shiga Toxin Derivatives from Escherichia coli Possess Adjuvant Activity for the Augmentation of Antigen-Specific Immune Responses via Dendritic Cell Activation Infect. Immun., July 1, 2005; 73(7): 4088 - 4097. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. J. Unger, F. Hauet-Broere, W. Jansen, L. A. van Berkel, G. Kraal, and J. N. Samsom Early Events in Peripheral Regulatory T Cell Induction via the Nasal Mucosa J. Immunol., November 1, 2003; 171(9): 4592 - 4603. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Kang, Q. Yao, L. Guo, and R. W. Compans Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus Conjugated with Cholera Toxin Subunit B J. Virol., September 15, 2003; 77(18): 9823 - 9830. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fischer, D. Rood, R. W. Barrette, A. Zuwallack, E. Kramer, F. Brown, and L. K. Silbart Intranasal Immunization of Guinea Pigs with an Immunodominant Foot-and-Mouth Disease Virus Peptide Conjugate Induces Mucosal and Humoral Antibodies and Protection against Challenge J. Virol., July 1, 2003; 77(13): 7486 - 7491. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Eriksson, M. Fredriksson, I. Nordstrom, and J. Holmgren Cholera Toxin and Its B Subunit Promote Dendritic Cell Vaccination with Different Influences on Th1 and Th2 Development Infect. Immun., April 1, 2003; 71(4): 1740 - 1747. [Abstract] [Full Text] |
||||
![]() |
S. A. Fraser, L. de Haan, A. R. Hearn, H. K. Bone, R. J. Salmond, A. J. Rivett, N. A. Williams, and T. R. Hirst Mutant Escherichia coli Heat-Labile Toxin B Subunit That Separates Toxoid-Mediated Signaling and Immunomodulatory Action from Trafficking and Delivery Functions Infect. Immun., March 1, 2003; 71(3): 1527 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Martin, A. Sharpe, J. D. Clements, and S. M. Michalek Role of B7 Costimulatory Molecules in the Adjuvant Activity of the Heat-Labile Enterotoxin of Escherichiacoli J. Immunol., August 15, 2002; 169(4): 1744 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Wu, W. F. Wade, and R. K. Taylor Evaluation of Cholera Vaccines Formulated with Toxin-Coregulated Pilin Peptide Plus Polymer Adjuvant in Mice Infect. Immun., December 1, 2001; 69(12): 7695 - 7702. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Qamar, S. Aboudola, M. Warny, P. Michetti, C. Pothoulakis, J. T. LaMont, and C. P. Kelly Saccharomyces boulardii Stimulates Intestinal Immunoglobulin A Immune Response to Clostridium difficile Toxin A in Mice Infect. Immun., April 1, 2001; 69(4): 2762 - 2765. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Robinson, T. G. Blanchard, A. D. Levine, S. N. Emancipator, and M. E. Lamm A Mucosal IgA-Mediated Excretory Immune System In Vivo J. Immunol., March 15, 2001; 166(6): 3688 - 3692. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bonenfant, I. Dimier-Poisson, F. Velge-Roussel, D. Buzoni-Gatel, G. Del Giudice, R. Rappuoli, and D. Bout Intranasal Immunization with SAG1 and Nontoxic Mutant Heat-Labile Enterotoxins Protects Mice against Toxoplasma gondii Infect. Immun., March 1, 2001; 69(3): 1605 - 1612. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kato, K. Fujihashi, R. Kato, Y. Yuki, and J. R. McGhee Oral Tolerance Revisited: Prior Oral Tolerization Abrogates Cholera Toxin-Induced Mucosal IgA Responses J. Immunol., March 1, 2001; 166(5): 3114 - 3121. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. van Ginkel, R. J. Jackson, Y. Yuki, and J. R. McGhee Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues J. Immunol., November 1, 2000; 165(9): 4778 - 4782. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Macpherson, D. Gatto, E. Sainsbury, G. R. Harriman, H. Hengartner, and R. M. Zinkernagel A Primitive T Cell-Independent Mechanism of Intestinal Mucosal IgA Responses to Commensal Bacteria Science, June 23, 2000; 288(5474): 2222 - 2226. [Abstract] [Full Text] |
||||
![]() |
R. Weltzin, B. Guy, W. D. Thomas Jr., P. J. Giannasca, and T. P. Monath Parenteral Adjuvant Activities of Escherichia coli Heat-Labile Toxin and Its B Subunit for Immunization of Mice against Gastric Helicobacter pylori Infection Infect. Immun., May 1, 2000; 68(5): 2775 - 2782. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Meydani and W.-K. Ha Immunologic effects of yogurt Am. J. Clinical Nutrition, April 1, 2000; 71(4): 861 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ricci, D. Medaglini, C. M. Rush, A. Marcello, S. Peppoloni, R. Manganelli, G. Palu, and G. Pozzi Immunogenicity of the B Monomer of Escherichia coli Heat-Labile Toxin Expressed on the Surface of Streptococcus gordonii Infect. Immun., February 1, 2000; 68(2): 760 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jakobsen, D. Schulz, M. Pizza, R. Rappuoli, and I. Jonsdottir Intranasal Immunization with Pneumococcal Polysaccharide Conjugate Vaccines with Nontoxic Mutants of Escherichia coli Heat-Labile Enterotoxins as Adjuvants Protects Mice against Invasive Pneumococcal Infections Infect. Immun., November 1, 1999; 67(11): 5892 - 5897. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Wiedermann, B. Jahn-Schmid, M. Lindblad, C. Rask, J. Holmgren, D. Kraft, and C. Ebner Int. Immunol., October 1, 1999; 11(10): 1717 - 1724. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Williamson, G. M. Westrich, and J. L. Viney Modulating Dendritic Cells to Optimize Mucosal Immunization Protocols J. Immunol., October 1, 1999; 163(7): 3668 - 3675. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Viret, D. Favre, B. Wegmuller, C. Herzog, J. U. Que, S. J. Cryz Jr., and A. B. Lang Mucosal and Systemic Immune Responses in Humans after Primary and Booster Immunizations with Orally Administered Invasive and Noninvasive Live Attenuated Bacteria Infect. Immun., July 1, 1999; 67(7): 3680 - 3685. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Wiedermann, B. Jahn-Schmid, M. Lindblad, C. Rask, J. Holmgren, D. Kraft, and C. Ebner Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy Int. Immunol., July 1, 1999; 11(7): 1131 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Staats and F. A. Ennis Jr. IL-1 Is an Effective Adjuvant for Mucosal and Systemic Immune Responses When Coadministered with Protein Immunogens J. Immunol., May 15, 1999; 162(10): 6141 - 6147. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Snider, H. Liang, I. Switzer, and B. J. Underdown IgA production in MHC class II-deficient mice is primarily a function of B-1a cells Int. Immunol., February 1, 1999; 11(2): 191 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Matousek, J. G. Nedrud, W. Cieplak Jr., and C. V. Harding Inhibition of Class II Major Histocompatibility Complex Antigen Processing by Escherichia coli Heat-Labile Enterotoxin Requires an Enzymatically Active A Subunit Infect. Immun., July 1, 1998; 66(7): 3480 - 3484. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Marcotte and M. C. Lavoie Oral Microbial Ecology and the Role of Salivary Immunoglobulin A Microbiol. Mol. Biol. Rev., March 1, 1998; 62(1): 71 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sultan, L.-l. Jin, M. G. Jobling, R. K. Holmes, and S. L. Stanley Jr. Mucosal Immunogenicity of a Holotoxin-Like Molecule Containing the Serine-Rich Entamoeba histolytica Protein (SREHP) Fused to the A2 Domain of Cholera Toxin Infect. Immun., February 1, 1998; 66(2): 462 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-H. Kim, L. Eckmann, W. J. Lee, W. Han, and M. F. Kagnoff Cholera Toxin and Cholera Toxin B Subunit Induce IgA Switching Through the Action of TGF-{beta}1 J. Immunol., February 1, 1998; 160(3): 1198 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ma, J. Mellon, and J. Y Niederkorn Oral immunisation as a strategy for enhancing corneal allograft survival Br. J. Ophthalmol., September 1, 1997; 81(9): 778 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamamoto, H. Kiyono, M. Yamamoto, K. Imaoka, M. Yamamoto, K. Fujihashi, F. W. Van Ginkel, M. Noda, Y. Takeda, and J. R. McGhee A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity PNAS, May 13, 1997; 94(10): 5267 - 5272. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamamoto, Y. Takeda, M. Yamamoto, H. Kurazono, K. Imaoka, M. Yamamoto, K. Fujihashi, M. Noda, H. Kiyono, and J. R. McGhee Mutants in the ADP-ribosyltransferase Cleft of Cholera Toxin Lack Diarrheagenicity but Retain Adjuvanticity J. Exp. Med., April 7, 1997; 185(7): 1203 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhu and R. A. Kahn The Escherichia coli Heat Labile Toxin Binds to Golgi Membranes and Alters Golgi and Cell Morphologies Using ADP-ribosylation Factor-dependent Processes J. Biol. Chem., June 29, 2001; 276(27): 25014 - 25021. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |